FDA approves Boehringer Ingelheim's Cyltezo for inflammatory ailments

The newly approved formulation will be offered as a pre-filled syringe or pre-filled autoinjector.

Related Keywords

Boehringer Ingelheim Biosimilar ,Boehringer Ingelheim Cyltezo ,Stephen Pagnotta ,Drug Administration ,Boehringer Ingelheim ,Ingelheim Biosimilar ,Ochre Bio ,Pharmaceutical Technology ,Fda ,Us Food And Drug Administration ,Inflammatory Diseases ,